Base Metals Investing Ryoncil® Receives J-Code From Medicare & Medicaid Services Facilitating Reimbursement and Broader Patient Access
Base Metals Investing Mesoblast Cell Therapy Products are Designated U.S. Origin and Not Subject to Tariffs
Base Metals Investing Successful Commercial Launch of Ryoncil® Highlighted at Global Healthcare Conferences
